Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients
Improved therapies are urgently needed for patients with diffuse large B cell lymphoma (DLBCL). Success using immune checkpoint inhibitors and chimeric antigen receptor T cell technology has fuelled demand for validated cancer epitopes. Immunogenic cancer testis antigens (CTAs), with their widesprea...
Saved in:
Main Authors: | Kamel Ait-Tahar, Amanda P. Anderson, Martin Barnardo, Graham P. Collins, Chris S. R. Hatton, Alison H. Banham, Karen Pulford |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2017/6527306 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypoxemic Bronchiolitis Related to Major Histocompatibility Class II Deficiency
by: S. Hammami, et al.
Published: (2013-01-01) -
Immunopathogenesis of spondyloarthropathies – Concept of major histocompatibility locus-I-opathy
by: Amlan Kusum Datta, et al.
Published: (2021-01-01) -
Geometry Dynamics of α-Helices in Different Class I Major Histocompatibility Complexes
by: Reiner Ribarics, et al.
Published: (2015-01-01) -
Association of Major Histocompatibility Complex Polymorphism With Acute Phase Response in Broiler Chicken
by: Afra Vatankhah, et al.
Published: (2024-11-01) -
Major Histocompatibility Complex Genes as Therapeutic Opportunity for Immune Cold Molecular Cancer Subtypes
by: Paweł Karpiński, et al.
Published: (2020-01-01)